These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6156436)

  • 1. [Polypeptide "substance P": pathophysiologic aspects].
    Gomazkov OA
    Patol Fiziol Eksp Ter; 1980; (2):75-83. PubMed ID: 6156436
    [No Abstract]   [Full Text] [Related]  

  • 2. Substance P.
    Pernow B
    Pharmacol Rev; 1983 Jun; 35(2):85-141. PubMed ID: 6196797
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis of substance P antagonists: [D-Pro4, D-Trp7,9,Nle11]-substance P(4-11).
    Köller G; Bienert M; Niedrich H; Bergmann J; Mezö I; Oehme P
    Pharmazie; 1984 Jan; 39(1):65-7. PubMed ID: 6201929
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of substance P on smooth musculature of the gastrointestinal tract (proceedings)].
    Nieber K; Milenov K; Oehme P; Bergmann J
    Pharmazie; 1979; 34(5-6):345-6. PubMed ID: 515151
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of smooth muscle contractions induced by capsaicin and electrical transmural stimulation by a substance P antagonist.
    Björkroth U
    Acta Physiol Scand Suppl; 1983; 515():11-6. PubMed ID: 6194652
    [No Abstract]   [Full Text] [Related]  

  • 6. Relationship between neuropeptides and gastrointestinal smooth muscle activity.
    Nieber K; Milenov K; Rakovska A; Oehme P
    Biomed Biochim Acta; 1989; 48(5-6):S565-8. PubMed ID: 2474292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterization of four related substance P antagonists.
    Björkroth U; Rosell S; Xu JC; Folkers K
    Acta Physiol Scand; 1982 Oct; 116(2):167-73. PubMed ID: 6188324
    [No Abstract]   [Full Text] [Related]  

  • 8. Substance P: pharmacology, properties, and mode of action.
    Oehme P; Piesche L; Hilse H; Bergmann J; Hecht K; Nieba K; Bienert M
    Vopr Biokhim Mozga; 1978; 13():168-76. PubMed ID: 388854
    [No Abstract]   [Full Text] [Related]  

  • 9. Regional differences in the response to substance P on the longitudinal muscle and the concentration of substance P in the digestive tract of the guinea-pig.
    Holzer P; Emson PC; Iversen LL; Sharman DF
    Neuroscience; 1981; 6(7):1433-41. PubMed ID: 6167901
    [No Abstract]   [Full Text] [Related]  

  • 10. Chimeric galanin analogs that function as antagonists in the CNS are full agonists in gastrointestinal smooth muscle.
    Gu ZF; Rossowski WJ; Coy DH; Pradhan TK; Jensen RT
    J Pharmacol Exp Ther; 1993 Aug; 266(2):912-8. PubMed ID: 7689105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Putative peptide neurotransmitters.
    Otsuka M; Takahashi T
    Annu Rev Pharmacol Toxicol; 1977; 17():425-39. PubMed ID: 17359
    [No Abstract]   [Full Text] [Related]  

  • 12. Different action of substance P on gastric and ileal smooth muscle.
    Nieber K; Oehme P; Milenov K
    Pharmazie; 1982 Sep; 37(9):656-8. PubMed ID: 6183682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of the reflex responses to muscle contraction by the coadministration of antagonists to substance P and somatostatin into the dorsal horn.
    Wilson LB; Wall PT; Matsukawa K
    Cardiovasc Res; 1995 Mar; 29(3):379-84. PubMed ID: 7540111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substance P and analogues: biological activity and degradation.
    Teichberg VI; Blumberg S
    Prog Biochem Pharmacol; 1980; 16():84-94. PubMed ID: 6160595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substance P and neurotensin in the control of gastrointestinal function.
    Rosell S
    Soc Gen Physiol Ser; 1980; 35():147-62. PubMed ID: 6158103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Substance P and salivary secretion].
    Lembeck F; Starke K
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 259(5):375-85. PubMed ID: 4236493
    [No Abstract]   [Full Text] [Related]  

  • 17. Peripheral and central nervous actions of substance P antagonists.
    Rosell S; Folkers K
    Adv Biochem Psychopharmacol; 1982; 33():471-6. PubMed ID: 6181662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropeptides and inflammation: the role of substance P.
    Payan DG
    Annu Rev Med; 1989; 40():341-52. PubMed ID: 2471450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of gastroesophageal reflux.
    Cohen S; Reynolds J; Boyle J; Ouyang A; Altshuler S
    Nihon Heikatsukin Gakkai Zasshi; 1985 Jul; 21 Suppl():93. PubMed ID: 2421038
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis of substance P analogs with arginine in position eleven.
    Sofuku S; Torigoe K; Muramatsu I
    Chem Pharm Bull (Tokyo); 1984 Oct; 32(10):4144-8. PubMed ID: 6085034
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.